A Risk-Based Case for Separating Production and Reporting Databases in 21 CFR Part 11 Environments

Why a two-database architecture protects production integrity, improves reporting performance, and supports a risk-based validation approach under 21 CFR Part 11. This white paper covers regulatory context, architecture comparison, no-code validation benefits, and implementation guidance for regulated life sciences manufacturing.